Barclays Maintains Overweight on Corteva, Lowers Price Target to $67
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer maintains an Overweight rating on Corteva (NYSE:CTVA) but lowers the price target from $70 to $67.
August 14, 2023 | 10:59 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on Corteva but lowers the price target from $70 to $67.
The news is directly related to Corteva and is likely to influence investor sentiment. While the Overweight rating is maintained, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100